Physician profile
Michael S Morrow
NPI 1013920420
$880.96
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $474 · 2020: $105 · 2022: $90.51 · 2023: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $210 · Education: $0.79.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $210.39 |
| Education | $0.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $123.81 | 2019-2023 | Freestyle Libre 2 |
| Amgen INC. | $106.03 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $97.95 | 2019-2023 | |
| Pfizer INC. | $87.01 | 2019-2023 | |
| Novo Nordisk INC | $67.12 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.95 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $48.81 | 2019-2023 | Farxiga |
| Astellas Pharma US INC | $46.42 | 2019-2023 | Myrbetriq |
| E.R. Squibb & Sons, L.L.C. | $42.77 | 2019-2023 | Eliquis |
| Shire North American Group INC | $40.94 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $35.42 | 2023 | |
| Janssen Pharmaceuticals, INC | $31.38 | 2019 | |
| Lilly USA, LLC | $24.88 | 2020-2023 | Mounjaro |
| Abbvie INC. | $19.85 | 2023 | |
| Insulet Corporation | $16.73 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $13.45 | 2023 | Givlaari |
| Horizon Therapeutics Plc | $11.73 | 2019 | |
| Glaxosmithkline, LLC. | $10.92 | 2019 | |
| Sumitomo Pharma America, INC. | $0.79 | 2023 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Morrow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.